跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Onsett 4 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Onsett 4
Approved
STANDARD
Onsett 4
Cadila Pharmaceuticals Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f9315b70e1d421db
Company
Cadila Pharmaceuticals Limited
Type
Standard
Approval Details
Approval Id
f9315b70e1d421db
Drug Approval Philippines Name
Onsett 4
Product Name
Onsett 4
Registration Number
DRP-6105
Brand Name
Onsett 4
Generic Name
Ondansetron (as hydrochloride dihydrate)
Dosage Form
Film-Coated Tablet
Dosage Strength
4 mg
Manufacturer
Cadila Pharmaceuticals Limited
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Company Detail Path
/organization/cadila-pharmaceuticals-limited
Issuance Date
27 May 2024
Expiry Date
08 April 2030
Pharmacologic Category
Antiemetic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f9315b70e1d421db
Type
Standard
Back to Philippines FDA Approvals